11532498 · Active · incorporated 7 years, 11 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Series B+
Develops disease-modifying therapies for neurodegenerative diseases, focusing on unlocking previously undruggable targets.
See the complete cap table with every shareholder, founder tags, dilution across 8 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.